All In MedTech

Company

Artivion

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Artivion is on our public-company list (ticker AORT). Names searched as well: CryoLife. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

AORT

NYSE · ARTIVION, INC.

Public float

$1.39B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$441M

Fiscal year ending Dec 31, 2025

Net income

$9.8M

Fiscal year ending Dec 31, 2025

R&D spending

$31.0M

Fiscal year ending Dec 31, 2025

Cash

$48.4M

As of Sep 30, 2026

Long-term debt

$364M

As of Sep 30, 2026

Shares outstanding

48.8M

As of Oct 30, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025–$13.1M––
2024–$5.7M$184M–
2023–$4.0M––
2022–$3.4M––
2021–$3.8M––

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Sep 2, 2020Equity

Issued in a merger or acquisition; not counted as money raised

$20.0M$20.0M27Rule 506(b)Form D ↗Sep 14, 2020

2 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
CRYOLIFE INC
Headquarters
Kennesaw, Georgia
Incorporated
Florida over five years before filing
Entity type
Corporation
Revenue range
Over $100,000,000
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    18 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is free with an account

    For Artivion we have 2 shareholders with 5% or more and 18 government grants totalling $2.9M.

    Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.

    Latest FDA decisions

    Search the Clearance Tracker

    4 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT07089576 · 132 participants (planned) · Start Nov 4, 2025 · Primary completion Apr 2028

      Device: Arcevo™ LSA Hybrid Stent Graft System · For: Aortic Arch Aneurysm; Aortic Arch Dissection; Chronic Aortic Dissection and 1 more

      Sites: Birmingham, Alabama; Los Angeles, California; Aurora, Colorado · 26 sites in all

    9 more trials with a free account

    Reports received

    29

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    1

    3.4% of reports

    Injury reports

    24

    83% of reports

    Death reports

    4

    14% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230200
    Jan 240100
    Feb 240200
    Mar 240300
    Apr 240300
    May 240600
    Jun 240200
    Jul 240210
    Aug 240100
    Sep 240000
    Oct 240310
    Nov 240610
    Dec 240100
    Jan 250310
    Feb 250000
    Mar 250300
    Apr 250210
    May 250100
    Jun 250100
    Jul 250210
    Aug 251500
    Sep 250400
    Oct 250200
    Nov 250200
    Dec 250300
    Jan 260410
    Feb 260000
    Mar 260010
    Apr 260000
    May 260100
    Jun 261100
    Jul 260320
    Aug 260600
    Sep 260300
    Oct 260100
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    2 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    100 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.